Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ingevity (NGVT) Shares Outstanding (Weighted Average) (2016 - 2025)

Ingevity (NGVT) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $36.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.28% to $36.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.2 million through Dec 2025, changed 0.28% year-over-year, with the annual reading at $36.2 million for FY2025, 0.28% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $36.2 million at Ingevity, roughly flat from $36.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $40.4 million in Q1 2021, with the low at $36.2 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $37.5 million, with a median of $36.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) decreased 5.56% in 2023, then rose 0.34% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $39.8 million in 2021, then decreased by 4.11% to $38.2 million in 2022, then dropped by 4.41% to $36.5 million in 2023, then fell by 0.47% to $36.3 million in 2024, then dropped by 0.28% to $36.2 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $36.2 million, $36.4 million, and $36.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.